Two Sigma Securities, LLC Aim Immuno Tech Inc. Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.35 - $0.61 $36,254 - $63,185	103,583 Added 483.58%	125,003 $46,000
Q1 2024 May 15, 2024	BUY	$0.33 - $0.48 $7,068 - $10,281	21,420 New	21,420 $10,000
Q3 2023 Nov 14, 2023	BUY	$0.44 - $0.71 $22,154 - $35,748	50,350 Added 488.88%	60,649 $27,000
Q2 2023 Aug 14, 2023	SELL	$0.4 - $0.67 $2,524 - $4,228	-6,311 Reduced 38.0%	10,299 $6,000
Q1 2023 May 15, 2023	BUY	$0.32 - $0.77 $697 - $1,677	2,179 Added 15.1%	16,610 $7,000
Q4 2022 Feb 14, 2023	BUY	$0.31 - $0.6 $4,473 - $8,658	14,431 New	14,431 $4,000
Q2 2022 Aug 15, 2022	BUY	$0.78 - $1.27 $24,290 - $39,550	31,142 New	31,142 $24,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $9.61M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.